Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group
P Comella, G Frasci, N Panza, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
Reumatismo
|
March 25, 2024
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy
A Fassio, G Porciello, G Carioli, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group
P Comella, G Frasci, N Panza, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
Reumatismo
|
March 25, 2024
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy
A Fassio, G Porciello, G Carioli, et al.
Page
of 3